A date has been set for Mohammed Farraj's full inquest after he died from a 'traumatic head injury' while working out ...

The Crescent is a 350-home estate, with 181 of the properties being built by Bellway. The £20,000 'incentive' can be added to ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Biogen (NASDAQ:BIIB) and Stoke Therapeutics (NASDAQ:STOK) said on Tuesday they are collaborating to develop and commercialize ...

Josh Sargent scores a second-half double to spark Norwich City to a win over Stoke City that revives their play-off hopes.

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, ...